Learn More
Medchemexpress LLC N-[4-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]phenyl]-1-(2-furanylmethyl)-5-oxo-pyrrolidinecarboxamide | 2784577-71-3 | MFCD00701047 | C24H19ClN4O4 | 1 ML

Supplier: Medchemexpress LLC HY15070010MM/1ML
RLX-33 is a potent, selective, and blood-brain barrier (BBB) penetrant relaxin family peptide 3 (RXFP3) antagonist. This compound blocks relaxin-3-induced ERK1/2 phosphorylation and can prevent the stimulation of food intake induced by the RXFP3-selective agonist R3/I5 in rats, making it suitable for metabolic syndrome research.
- Potent and selective RXFP3 antagonist
- Blood-brain barrier penetrant
- Blocks relaxin-3-induced ERK1/2 phosphorylation
- Attenuates R3/I5-induced feeding
- Good brain penetration
- Highly protein-bound in rat plasma
- Useful for metabolic syndrome research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.